Home / Territories / Real estate: opportunities / Lyon Gerland Biopôle

Lyon Gerland: real-estate (invest, set up and relocate)

intelligent, accessible and alive

Located at the south entrance to Lyon close to the beltway and the highway, the Lyon Gerland district continues its modernization by attracting an increasing number of smaller innovative businesses.

Although lodgings continue to be built over the entire Lyon Gerland area, there is a preference for office buildings in the north, and the Biopôle is anchored in the south.

An efficient and vital territory

Lyon Gerland perspective Nord IGFL

Formerly an industrial district, Lyon Gerland has turned the corner toward innovation while maintaining its industrial heavyweights: Velan, Babolat, Nexans, SITL and Thermilyon.

Today, the district benefits from social and professional mixing that is leading to great economic dynamism.

With a transformation accompanied by an ambitious urban project, the district is home to a broad variety of industrial and service industries and shows good demographical growth.

Accessibility

The Jean Macé station is central to the Lyon Gerland district: with 5,000 daily travelers, it is Lyon’s third-largest station.

Around it, the multimodal hub links:

  • several bus lines,
  • metro line B,
  • tramway T2,
  • a Vélo’V station and
  • an Autolib’ station.

In 2014, metro line B will be extended to Oullins, and tramway T1 will connect Lyon Confluence and Debourg to reinforce the links between these two districts undergoing an economic, urban and demographic boom.

An alternative to Lyon Part-Dieu

With prices that are less by 20% than those of Lyon Part-Dieu, Lyon Gerland is driven by a complementary dynamic of development and innovation.

A pool of around 30,000 jobs makes this an attractive territory for offering company services.

In addition to major cultural and sports facilities like the Tony Garnier Hall or the Gerland stadium, it features the city’s second largest urban park along the banks of the Rhône.

It is also home to:

  • the largest climbing wall in France,
  • venues for theater and sports and
  • restaurants.

World-class science and research

In the south, the Lyon Gerland Biopôle brings together

  • world leaders:
    • Sanofi Pasteur,
    • Merial,
    • Genzyme, etc.
  • innovative smaller companies:
    • Aguettant,
    • Episkin,
    • Genoway,
    • Imaxio, etc.
  • and institutes of higher learning and research:
    • the Ecole Normale Supérieure de Lyon,
    • the Institute of Biology and Chemistry of Proteins,
    • Inserm, etc.

The site is also home to

  • over 2,000 public and private research scientists and
  • cutting-edge infrastructures like
    • the P4 Laboratory,
    • the Institute of Functional Genomics of Lyon and
    • the acClnov innovation platform.

The presence of Lyonbiopôle, a worldclass competitiveness cluster focusing on infectious diseases, reinforces Biopôle attractiveness.

This stimulating environment motivates the implantation of innovative smaller companies and the development of projects in the areas of vaccines, diagnosis and immunology.

Biopôle moves forward

With the Charles-Mérieux Campus project, the agglomeration aims to reinforce scientific and university excellence over the territory.

The Center for Advanced Research will soon bring together

  • the House of Social Science Research,
  • the Blaise Pascal Center and
  • the House of Insurance and Actuarial Science.

New infrastructures will house collaborative R&D projects:

  • the Center for Infectious Diseases,
    • with 1,980 m² of P2 and P3 laboratories and
    • 80 public and private research scientists;
  • the acCInov innovation platform, which will be delivered in 2013.

In 2017, the Technological Research Institute for Infectious Diseases, which will be housed in a new 30,000 m2 real estate complex, will strengthen the position of Lyon Gerland as a reference in scientific and technological innovation for biomedical purposes.

Two new projects

Techsud, a 19-hectare business park

Lyon Gerland Techsud, Genzyme perspective

This program proposes 100,000 m2 of net surface area divided into offices (80%) and activity areas (20%), since public areas have already been finished.

Genzyme, a world leader in medical biotechnology, currently occupies 3.7 hectares with a 22,000 m2 bio-production unit.

Adapei is also installed in the park and offers services to employees, such as dry cleaning, meals and upkeep of green areas.

Techsud is located inside the Lyon Gerland Biopôle close to Avenue Tony-Garnier.

The Girondins business area

perspective ZAC des Girondins à Lyon Gerland

Located in the north of the Lyon Gerland district, this 17 hectare territory is one of the last major land development areas in Lyon city center.

It is a mixed project aiming to create a new urban center, an exceptional opportunity in the heart of Lyon Gerland.

The program includes 100,000 m2 of net surface area for offices, with 30,000 m2 deliverable within two years.

Real estate: map of setting up and investment opportunities

Click the site of your choice on the map and discover its full data sheet!

map of sites to set up in and invest in Greater Lyon Lyon Vaise digital cluster Western Lyon economic cluster Cite internationale of Lyon Carre de Soie Lyon Part Dieu Lyon Confluence Lyon Gerland Biopole Lyon technology park Lyon-Saint Exupery airport Chemical Valley Northern Isere territory Plaine de l'Ain industrial park Agri-food and distribution center (Corbas) Lyon Bioparc (health) Urban East park Gaulnes industrial park LyonTech

Mipim 2012: the Lyon Gerland project, presented by the director of the Gerland Mission (French version with English subtitles)


Get Flash to see this player.

Duration: 04m 14s
Source: Bigbang communication - Grand Lyon
Date: 2012
"The Lyon Gerland Project: the District of Possibility", presented by Didier Budin, Director of the Guerland Mission (French version with English subtitles). This interview took place at Cannes in March 2012 during MIPIM, the business real estate show. Gerland, a former industrial district, has known how to adapt to innovation. Today, the district benefits from a social and professional interaction that has given rise to a strong economic dynamism. Supported during its transformation by an ambitious urban project, Gerland presents a broad variety of industrial and service companies and real functional diversity.

Start-up incubators

Technological research institute, worldwide center for infectious diseases

In 2017, the implantation of the technological research institute at the heart of a 40,000 m2 real estate complex will give the Lyon Gerland Biopôle the status of a worldwide reference campus for scientific and technological innovation for biomedical purposes.

Meeting tomorow's challenges

Powered by funding from the French government, Greater Lyon, the Rhône-Alpes Region and leading industrial companies (Sanofi, Institut Mérieux and Danone Research), the Foundation must create the conditions for effective synergy between infectious disease players to meet three challenges:

  • take overall and personalized charge of the infectious diseases that cause 14 million deaths worldwide each year, in particular respiratory diseases, diarrhea, AIDS, tuberculosis and septicemia;
  • break down the barriers between research and medical applications to increase the capacity for innovation;
  • promote economic development of health industries and technologies to reinforce France’s leadership on a worldwide level.

The presence of world leaders will contribute to the emergence of new start-ups and mid-sized companies.

The cumulative budget for the institute is estimated to be 800 M€ over a ten-year period.

Technological research institute founders

  • 2 co-leaders: Lyonbiopôle, Institut Pasteur
  • 3 leading industrial companies: Sanofi, Institut Mérieux, Danone Research
  • 3 research organisms: Inserm, CNRS, CEA
  • 1 group of nearly 50 smaller companies from the Rhône-Alpes region and Île-de-France

Five technological platforms

  • collection and characterization of pathogens
  • characterization and tracking of the host response
  • bio-production by design
  • prototyping technologies for medicines and vaccines
  • ICT and data management

Starting programs

At the start, three structuring programs will federate the resources of several disciplines. They will be product-oriented and use the technologies developed on the technological platforms. They will concern:

  • new therapies and vaccines,
  • real-time diagnosis and
  • the intestinal microbiota as an indicator of health and a health product.

For the first three years, 145 M€ will be invested by public and private actors to support approximately forty R&D projects.

For 2020

  • 1,000 research workers dedicated to technological research
  • 40,000 m2 of specially dedicated building surface
  • 800 M€ budget over ten years
  • 10,000 direct and indirect jobs created

Key figures

  • 100,000 m2 of net surface area with office potential
  • 2,000 companies
  • 30,000 jobs, including
  • 3,000 students
  • 2,000 research scientists and teacher-researchers, including
  • 30 public research laboratories
  • €190 to €215 / m2 / year for new prime rentals
  • 500,000 m2 of net surface area in the existing business park, including
    • 200,000 m2 built between 2000 and 2011
  • 10,000 m2 placed each year for the past ten years and
    • 24,000 m2 in 2011

Related file